| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-12 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |